nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—CYP1A2—Clobetasol propionate—psoriasis	0.0601	0.0961	CbGbCtD
Imipramine—CYP2B6—Cholecalciferol—psoriasis	0.0357	0.057	CbGbCtD
Imipramine—CYP1A2—Methoxsalen—psoriasis	0.0316	0.0505	CbGbCtD
Imipramine—CYP2D6—Hydroxyurea—psoriasis	0.0284	0.0455	CbGbCtD
Imipramine—CYP3A7—Hydrocortisone—psoriasis	0.0261	0.0417	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.0261	0.0417	CbGbCtD
Imipramine—CYP3A7—Cyclosporine—psoriasis	0.0246	0.0394	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0246	0.0394	CbGbCtD
Imipramine—CYP2C19—Cholecalciferol—psoriasis	0.0227	0.0362	CbGbCtD
Imipramine—CYP3A4—Calcitriol—psoriasis	0.0213	0.034	CbGbCtD
Imipramine—CYP2D6—Cholecalciferol—psoriasis	0.0172	0.0275	CbGbCtD
Imipramine—CYP3A4—Methoxsalen—psoriasis	0.0165	0.0264	CbGbCtD
Imipramine—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0162	0.0259	CbGbCtD
Imipramine—CYP3A7—Dexamethasone—psoriasis	0.0162	0.0259	CbGbCtD
Imipramine—ABCB1—Mycophenolate mofetil—psoriasis	0.0159	0.0254	CbGbCtD
Imipramine—CYP2C19—Prednisone—psoriasis	0.0157	0.0251	CbGbCtD
Imipramine—CYP2E1—Dexamethasone—psoriasis	0.0156	0.025	CbGbCtD
Imipramine—CYP2B6—Dexamethasone—psoriasis	0.0154	0.0247	CbGbCtD
Imipramine—CYP2C19—Cyclosporine—psoriasis	0.0149	0.0238	CbGbCtD
Imipramine—ABCB1—Betamethasone—psoriasis	0.0136	0.0217	CbGbCtD
Imipramine—ABCB1—Prednisolone—psoriasis	0.0134	0.0215	CbGbCtD
Imipramine—ABCB1—Hydrocortisone—psoriasis	0.0127	0.0203	CbGbCtD
Imipramine—ABCB1—Prednisone—psoriasis	0.0127	0.0203	CbGbCtD
Imipramine—ABCB1—Cyclosporine—psoriasis	0.012	0.0192	CbGbCtD
Imipramine—CYP2D6—Cyclosporine—psoriasis	0.0113	0.0181	CbGbCtD
Imipramine—CYP3A4—Cholecalciferol—psoriasis	0.011	0.0175	CbGbCtD
Imipramine—CYP2C19—Dexamethasone—psoriasis	0.00981	0.0157	CbGbCtD
Imipramine—CYP3A4—Mycophenolate mofetil—psoriasis	0.0095	0.0152	CbGbCtD
Imipramine—CYP3A4—Triamcinolone—psoriasis	0.0095	0.0152	CbGbCtD
Imipramine—CYP3A4—Betamethasone—psoriasis	0.00815	0.013	CbGbCtD
Imipramine—CYP3A4—Prednisolone—psoriasis	0.00804	0.0129	CbGbCtD
Imipramine—ABCB1—Dexamethasone—psoriasis	0.00791	0.0127	CbGbCtD
Imipramine—CYP3A4—Hydrocortisone—psoriasis	0.00762	0.0122	CbGbCtD
Imipramine—CYP3A4—Prednisone—psoriasis	0.0076	0.0121	CbGbCtD
Imipramine—CYP2D6—Dexamethasone—psoriasis	0.00746	0.0119	CbGbCtD
Imipramine—CYP3A4—Cyclosporine—psoriasis	0.0072	0.0115	CbGbCtD
Imipramine—ABCB1—Methotrexate—psoriasis	0.00636	0.0102	CbGbCtD
Imipramine—CYP3A4—Dexamethasone—psoriasis	0.00474	0.00758	CbGbCtD
Imipramine—Anaphylactic shock—Triamcinolone—psoriasis	0.000158	0.000528	CcSEcCtD
Imipramine—Oedema—Triamcinolone—psoriasis	0.000158	0.000528	CcSEcCtD
Imipramine—Syncope—Betamethasone—psoriasis	0.000158	0.000526	CcSEcCtD
Imipramine—Syncope—Dexamethasone—psoriasis	0.000158	0.000526	CcSEcCtD
Imipramine—Constipation—Mycophenolate mofetil—psoriasis	0.000158	0.000526	CcSEcCtD
Imipramine—Arrhythmia—Prednisone—psoriasis	0.000157	0.000524	CcSEcCtD
Imipramine—Infection—Triamcinolone—psoriasis	0.000157	0.000524	CcSEcCtD
Imipramine—Feeling abnormal—Cyclosporine—psoriasis	0.000156	0.00052	CcSEcCtD
Imipramine—Shock—Triamcinolone—psoriasis	0.000156	0.000519	CcSEcCtD
Imipramine—Insomnia—Prednisolone—psoriasis	0.000156	0.000519	CcSEcCtD
Imipramine—Alopecia—Prednisone—psoriasis	0.000156	0.000519	CcSEcCtD
Imipramine—Hepatobiliary disease—Methotrexate—psoriasis	0.000155	0.000517	CcSEcCtD
Imipramine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000155	0.000516	CcSEcCtD
Imipramine—Loss of consciousness—Dexamethasone—psoriasis	0.000155	0.000516	CcSEcCtD
Imipramine—Loss of consciousness—Betamethasone—psoriasis	0.000155	0.000516	CcSEcCtD
Imipramine—Dizziness—Mycophenolic acid—psoriasis	0.000155	0.000516	CcSEcCtD
Imipramine—Paraesthesia—Prednisolone—psoriasis	0.000155	0.000515	CcSEcCtD
Imipramine—Tachycardia—Triamcinolone—psoriasis	0.000154	0.000515	CcSEcCtD
Imipramine—Mental disorder—Prednisone—psoriasis	0.000154	0.000514	CcSEcCtD
Imipramine—Malnutrition—Prednisone—psoriasis	0.000153	0.000511	CcSEcCtD
Imipramine—Hyperhidrosis—Triamcinolone—psoriasis	0.000153	0.00051	CcSEcCtD
Imipramine—Agranulocytosis—Methotrexate—psoriasis	0.000153	0.00051	CcSEcCtD
Imipramine—Convulsion—Dexamethasone—psoriasis	0.000152	0.000508	CcSEcCtD
Imipramine—Convulsion—Betamethasone—psoriasis	0.000152	0.000508	CcSEcCtD
Imipramine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000152	0.000507	CcSEcCtD
Imipramine—Insomnia—Hydrocortisone—psoriasis	0.000152	0.000507	CcSEcCtD
Imipramine—Hypertension—Betamethasone—psoriasis	0.000152	0.000507	CcSEcCtD
Imipramine—Hypertension—Dexamethasone—psoriasis	0.000152	0.000507	CcSEcCtD
Imipramine—Paraesthesia—Hydrocortisone—psoriasis	0.000151	0.000503	CcSEcCtD
Imipramine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000151	0.000503	CcSEcCtD
Imipramine—Urticaria—Cyclosporine—psoriasis	0.00015	0.000501	CcSEcCtD
Imipramine—Abdominal pain—Cyclosporine—psoriasis	0.000149	0.000499	CcSEcCtD
Imipramine—Body temperature increased—Cyclosporine—psoriasis	0.000149	0.000499	CcSEcCtD
Imipramine—Anxiety—Dexamethasone—psoriasis	0.000149	0.000498	CcSEcCtD
Imipramine—Anxiety—Betamethasone—psoriasis	0.000149	0.000498	CcSEcCtD
Imipramine—Vomiting—Mycophenolic acid—psoriasis	0.000149	0.000496	CcSEcCtD
Imipramine—Discomfort—Betamethasone—psoriasis	0.000148	0.000494	CcSEcCtD
Imipramine—Discomfort—Dexamethasone—psoriasis	0.000148	0.000494	CcSEcCtD
Imipramine—Dyspepsia—Hydrocortisone—psoriasis	0.000148	0.000493	CcSEcCtD
Imipramine—Rash—Mycophenolic acid—psoriasis	0.000147	0.000492	CcSEcCtD
Imipramine—Dermatitis—Mycophenolic acid—psoriasis	0.000147	0.000491	CcSEcCtD
Imipramine—Hepatitis—Methotrexate—psoriasis	0.000147	0.000491	CcSEcCtD
Imipramine—Urticaria—Mycophenolate mofetil—psoriasis	0.000147	0.000489	CcSEcCtD
Imipramine—Headache—Mycophenolic acid—psoriasis	0.000146	0.000488	CcSEcCtD
Imipramine—Decreased appetite—Hydrocortisone—psoriasis	0.000146	0.000487	CcSEcCtD
Imipramine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000146	0.000486	CcSEcCtD
Imipramine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000146	0.000486	CcSEcCtD
Imipramine—Urinary tract disorder—Methotrexate—psoriasis	0.000145	0.000484	CcSEcCtD
Imipramine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000145	0.000484	CcSEcCtD
Imipramine—Fatigue—Hydrocortisone—psoriasis	0.000145	0.000483	CcSEcCtD
Imipramine—Vision blurred—Prednisone—psoriasis	0.000144	0.000482	CcSEcCtD
Imipramine—Urethral disorder—Methotrexate—psoriasis	0.000144	0.000481	CcSEcCtD
Imipramine—Oedema—Betamethasone—psoriasis	0.000144	0.000479	CcSEcCtD
Imipramine—Anaphylactic shock—Betamethasone—psoriasis	0.000144	0.000479	CcSEcCtD
Imipramine—Anaphylactic shock—Dexamethasone—psoriasis	0.000144	0.000479	CcSEcCtD
Imipramine—Oedema—Dexamethasone—psoriasis	0.000144	0.000479	CcSEcCtD
Imipramine—Insomnia—Triamcinolone—psoriasis	0.000143	0.000477	CcSEcCtD
Imipramine—Infection—Dexamethasone—psoriasis	0.000143	0.000476	CcSEcCtD
Imipramine—Infection—Betamethasone—psoriasis	0.000143	0.000476	CcSEcCtD
Imipramine—Ill-defined disorder—Prednisone—psoriasis	0.000142	0.000474	CcSEcCtD
Imipramine—Paraesthesia—Triamcinolone—psoriasis	0.000142	0.000474	CcSEcCtD
Imipramine—Feeling abnormal—Prednisolone—psoriasis	0.000142	0.000473	CcSEcCtD
Imipramine—Shock—Dexamethasone—psoriasis	0.000141	0.000471	CcSEcCtD
Imipramine—Shock—Betamethasone—psoriasis	0.000141	0.000471	CcSEcCtD
Imipramine—Nervous system disorder—Betamethasone—psoriasis	0.000141	0.00047	CcSEcCtD
Imipramine—Nervous system disorder—Dexamethasone—psoriasis	0.000141	0.00047	CcSEcCtD
Imipramine—Agitation—Prednisone—psoriasis	0.000141	0.00047	CcSEcCtD
Imipramine—Thrombocytopenia—Betamethasone—psoriasis	0.000141	0.000469	CcSEcCtD
Imipramine—Thrombocytopenia—Dexamethasone—psoriasis	0.000141	0.000469	CcSEcCtD
Imipramine—Tachycardia—Dexamethasone—psoriasis	0.00014	0.000467	CcSEcCtD
Imipramine—Tachycardia—Betamethasone—psoriasis	0.00014	0.000467	CcSEcCtD
Imipramine—Dyspepsia—Triamcinolone—psoriasis	0.000139	0.000465	CcSEcCtD
Imipramine—Nausea—Mycophenolic acid—psoriasis	0.000139	0.000463	CcSEcCtD
Imipramine—Hyperhidrosis—Dexamethasone—psoriasis	0.000139	0.000463	CcSEcCtD
Imipramine—Hyperhidrosis—Betamethasone—psoriasis	0.000139	0.000463	CcSEcCtD
Imipramine—Feeling abnormal—Hydrocortisone—psoriasis	0.000138	0.000462	CcSEcCtD
Imipramine—Malaise—Prednisone—psoriasis	0.000138	0.000461	CcSEcCtD
Imipramine—Eye disorder—Methotrexate—psoriasis	0.000137	0.000458	CcSEcCtD
Imipramine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000137	0.000458	CcSEcCtD
Imipramine—Syncope—Prednisone—psoriasis	0.000137	0.000458	CcSEcCtD
Imipramine—Tinnitus—Methotrexate—psoriasis	0.000137	0.000457	CcSEcCtD
Imipramine—Anorexia—Betamethasone—psoriasis	0.000137	0.000456	CcSEcCtD
Imipramine—Anorexia—Dexamethasone—psoriasis	0.000137	0.000456	CcSEcCtD
Imipramine—Urticaria—Prednisolone—psoriasis	0.000137	0.000456	CcSEcCtD
Imipramine—Cardiac disorder—Methotrexate—psoriasis	0.000137	0.000455	CcSEcCtD
Imipramine—Fatigue—Triamcinolone—psoriasis	0.000136	0.000455	CcSEcCtD
Imipramine—Asthenia—Cyclosporine—psoriasis	0.000136	0.000452	CcSEcCtD
Imipramine—Loss of consciousness—Prednisone—psoriasis	0.000135	0.000449	CcSEcCtD
Imipramine—Pruritus—Cyclosporine—psoriasis	0.000134	0.000446	CcSEcCtD
Imipramine—Urticaria—Hydrocortisone—psoriasis	0.000134	0.000445	CcSEcCtD
Imipramine—Angiopathy—Methotrexate—psoriasis	0.000133	0.000445	CcSEcCtD
Imipramine—Immune system disorder—Methotrexate—psoriasis	0.000133	0.000443	CcSEcCtD
Imipramine—Abdominal pain—Hydrocortisone—psoriasis	0.000133	0.000443	CcSEcCtD
Imipramine—Body temperature increased—Hydrocortisone—psoriasis	0.000133	0.000443	CcSEcCtD
Imipramine—Convulsion—Prednisone—psoriasis	0.000133	0.000443	CcSEcCtD
Imipramine—Mediastinal disorder—Methotrexate—psoriasis	0.000133	0.000442	CcSEcCtD
Imipramine—Asthenia—Mycophenolate mofetil—psoriasis	0.000132	0.000441	CcSEcCtD
Imipramine—Hypertension—Prednisone—psoriasis	0.000132	0.000441	CcSEcCtD
Imipramine—Pruritus—Mycophenolate mofetil—psoriasis	0.000131	0.000435	CcSEcCtD
Imipramine—Feeling abnormal—Triamcinolone—psoriasis	0.00013	0.000435	CcSEcCtD
Imipramine—Anxiety—Prednisone—psoriasis	0.00013	0.000434	CcSEcCtD
Imipramine—Alopecia—Methotrexate—psoriasis	0.00013	0.000433	CcSEcCtD
Imipramine—Insomnia—Dexamethasone—psoriasis	0.00013	0.000433	CcSEcCtD
Imipramine—Insomnia—Betamethasone—psoriasis	0.00013	0.000433	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.00013	0.000432	CcSEcCtD
Imipramine—Diarrhoea—Cyclosporine—psoriasis	0.000129	0.000432	CcSEcCtD
Imipramine—Paraesthesia—Dexamethasone—psoriasis	0.000129	0.00043	CcSEcCtD
Imipramine—Paraesthesia—Betamethasone—psoriasis	0.000129	0.00043	CcSEcCtD
Imipramine—Discomfort—Prednisone—psoriasis	0.000129	0.00043	CcSEcCtD
Imipramine—Mental disorder—Methotrexate—psoriasis	0.000129	0.00043	CcSEcCtD
Imipramine—Malnutrition—Methotrexate—psoriasis	0.000128	0.000427	CcSEcCtD
Imipramine—Dyspepsia—Dexamethasone—psoriasis	0.000126	0.000422	CcSEcCtD
Imipramine—Dyspepsia—Betamethasone—psoriasis	0.000126	0.000422	CcSEcCtD
Imipramine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000126	0.000421	CcSEcCtD
Imipramine—Urticaria—Triamcinolone—psoriasis	0.000126	0.000419	CcSEcCtD
Imipramine—Dysgeusia—Methotrexate—psoriasis	0.000125	0.000418	CcSEcCtD
Imipramine—Body temperature increased—Triamcinolone—psoriasis	0.000125	0.000417	CcSEcCtD
Imipramine—Dizziness—Cyclosporine—psoriasis	0.000125	0.000417	CcSEcCtD
Imipramine—Oedema—Prednisone—psoriasis	0.000125	0.000417	CcSEcCtD
Imipramine—Anaphylactic shock—Prednisone—psoriasis	0.000125	0.000417	CcSEcCtD
Imipramine—Decreased appetite—Dexamethasone—psoriasis	0.000125	0.000416	CcSEcCtD
Imipramine—Decreased appetite—Betamethasone—psoriasis	0.000125	0.000416	CcSEcCtD
Imipramine—Infection—Prednisone—psoriasis	0.000124	0.000414	CcSEcCtD
Imipramine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000124	0.000413	CcSEcCtD
Imipramine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000124	0.000413	CcSEcCtD
Imipramine—Fatigue—Dexamethasone—psoriasis	0.000124	0.000413	CcSEcCtD
Imipramine—Fatigue—Betamethasone—psoriasis	0.000124	0.000413	CcSEcCtD
Imipramine—Shock—Prednisone—psoriasis	0.000123	0.00041	CcSEcCtD
Imipramine—Nervous system disorder—Prednisone—psoriasis	0.000123	0.000409	CcSEcCtD
Imipramine—Tachycardia—Prednisone—psoriasis	0.000122	0.000407	CcSEcCtD
Imipramine—Dizziness—Mycophenolate mofetil—psoriasis	0.000122	0.000407	CcSEcCtD
Imipramine—Skin disorder—Prednisone—psoriasis	0.000121	0.000405	CcSEcCtD
Imipramine—Hyperhidrosis—Prednisone—psoriasis	0.000121	0.000403	CcSEcCtD
Imipramine—Vision blurred—Methotrexate—psoriasis	0.000121	0.000402	CcSEcCtD
Imipramine—Asthenia—Hydrocortisone—psoriasis	0.000121	0.000402	CcSEcCtD
Imipramine—Vomiting—Cyclosporine—psoriasis	0.00012	0.000401	CcSEcCtD
Imipramine—Rash—Cyclosporine—psoriasis	0.000119	0.000398	CcSEcCtD
Imipramine—Anorexia—Prednisone—psoriasis	0.000119	0.000398	CcSEcCtD
Imipramine—Dermatitis—Cyclosporine—psoriasis	0.000119	0.000397	CcSEcCtD
Imipramine—Pruritus—Hydrocortisone—psoriasis	0.000119	0.000397	CcSEcCtD
Imipramine—Ill-defined disorder—Methotrexate—psoriasis	0.000119	0.000396	CcSEcCtD
Imipramine—Headache—Cyclosporine—psoriasis	0.000118	0.000395	CcSEcCtD
Imipramine—Feeling abnormal—Dexamethasone—psoriasis	0.000118	0.000395	CcSEcCtD
Imipramine—Feeling abnormal—Betamethasone—psoriasis	0.000118	0.000395	CcSEcCtD
Imipramine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000117	0.000392	CcSEcCtD
Imipramine—Gastrointestinal pain—Betamethasone—psoriasis	0.000117	0.000392	CcSEcCtD
Imipramine—Vomiting—Mycophenolate mofetil—psoriasis	0.000117	0.000391	CcSEcCtD
Imipramine—Rash—Mycophenolate mofetil—psoriasis	0.000116	0.000388	CcSEcCtD
Imipramine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000116	0.000388	CcSEcCtD
Imipramine—Headache—Mycophenolate mofetil—psoriasis	0.000116	0.000385	CcSEcCtD
Imipramine—Malaise—Methotrexate—psoriasis	0.000115	0.000385	CcSEcCtD
Imipramine—Diarrhoea—Hydrocortisone—psoriasis	0.000115	0.000383	CcSEcCtD
Imipramine—Leukopenia—Methotrexate—psoriasis	0.000115	0.000382	CcSEcCtD
Imipramine—Urticaria—Betamethasone—psoriasis	0.000114	0.00038	CcSEcCtD
Imipramine—Urticaria—Dexamethasone—psoriasis	0.000114	0.00038	CcSEcCtD
Imipramine—Dizziness—Prednisolone—psoriasis	0.000114	0.000379	CcSEcCtD
Imipramine—Asthenia—Triamcinolone—psoriasis	0.000114	0.000379	CcSEcCtD
Imipramine—Body temperature increased—Dexamethasone—psoriasis	0.000114	0.000379	CcSEcCtD
Imipramine—Abdominal pain—Dexamethasone—psoriasis	0.000114	0.000379	CcSEcCtD
Imipramine—Abdominal pain—Betamethasone—psoriasis	0.000114	0.000379	CcSEcCtD
Imipramine—Body temperature increased—Betamethasone—psoriasis	0.000114	0.000379	CcSEcCtD
Imipramine—Insomnia—Prednisone—psoriasis	0.000113	0.000377	CcSEcCtD
Imipramine—Nausea—Cyclosporine—psoriasis	0.000112	0.000375	CcSEcCtD
Imipramine—Paraesthesia—Prednisone—psoriasis	0.000112	0.000374	CcSEcCtD
Imipramine—Pruritus—Triamcinolone—psoriasis	0.000112	0.000373	CcSEcCtD
Imipramine—Dizziness—Hydrocortisone—psoriasis	0.000111	0.000371	CcSEcCtD
Imipramine—Convulsion—Methotrexate—psoriasis	0.000111	0.00037	CcSEcCtD
Imipramine—Dyspepsia—Prednisone—psoriasis	0.00011	0.000367	CcSEcCtD
Imipramine—Nausea—Mycophenolate mofetil—psoriasis	0.00011	0.000365	CcSEcCtD
Imipramine—Decreased appetite—Prednisone—psoriasis	0.000109	0.000363	CcSEcCtD
Imipramine—Rash—Prednisolone—psoriasis	0.000109	0.000362	CcSEcCtD
Imipramine—Dermatitis—Prednisolone—psoriasis	0.000108	0.000362	CcSEcCtD
Imipramine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000108	0.000361	CcSEcCtD
Imipramine—Fatigue—Prednisone—psoriasis	0.000108	0.00036	CcSEcCtD
Imipramine—Headache—Prednisolone—psoriasis	0.000108	0.00036	CcSEcCtD
Imipramine—Discomfort—Methotrexate—psoriasis	0.000108	0.000359	CcSEcCtD
Imipramine—Constipation—Prednisone—psoriasis	0.000107	0.000357	CcSEcCtD
Imipramine—Vomiting—Hydrocortisone—psoriasis	0.000107	0.000356	CcSEcCtD
Imipramine—Rash—Hydrocortisone—psoriasis	0.000106	0.000353	CcSEcCtD
Imipramine—Dermatitis—Hydrocortisone—psoriasis	0.000106	0.000353	CcSEcCtD
Imipramine—Confusional state—Methotrexate—psoriasis	0.000105	0.000351	CcSEcCtD
Imipramine—Headache—Hydrocortisone—psoriasis	0.000105	0.000351	CcSEcCtD
Imipramine—Dizziness—Triamcinolone—psoriasis	0.000105	0.000349	CcSEcCtD
Imipramine—Anaphylactic shock—Methotrexate—psoriasis	0.000105	0.000349	CcSEcCtD
Imipramine—Infection—Methotrexate—psoriasis	0.000104	0.000346	CcSEcCtD
Imipramine—Feeling abnormal—Prednisone—psoriasis	0.000103	0.000344	CcSEcCtD
Imipramine—Asthenia—Betamethasone—psoriasis	0.000103	0.000344	CcSEcCtD
Imipramine—Asthenia—Dexamethasone—psoriasis	0.000103	0.000344	CcSEcCtD
Imipramine—Nervous system disorder—Methotrexate—psoriasis	0.000102	0.000342	CcSEcCtD
Imipramine—Thrombocytopenia—Methotrexate—psoriasis	0.000102	0.000341	CcSEcCtD
Imipramine—Gastrointestinal pain—Prednisone—psoriasis	0.000102	0.000341	CcSEcCtD
Imipramine—Nausea—Prednisolone—psoriasis	0.000102	0.000341	CcSEcCtD
Imipramine—Pruritus—Dexamethasone—psoriasis	0.000102	0.000339	CcSEcCtD
Imipramine—Pruritus—Betamethasone—psoriasis	0.000102	0.000339	CcSEcCtD
Imipramine—Skin disorder—Methotrexate—psoriasis	0.000102	0.000339	CcSEcCtD
Imipramine—Hyperhidrosis—Methotrexate—psoriasis	0.000101	0.000337	CcSEcCtD
Imipramine—Vomiting—Triamcinolone—psoriasis	0.000101	0.000336	CcSEcCtD
Imipramine—Nausea—Hydrocortisone—psoriasis	9.98e-05	0.000333	CcSEcCtD
Imipramine—Rash—Triamcinolone—psoriasis	9.98e-05	0.000333	CcSEcCtD
Imipramine—Dermatitis—Triamcinolone—psoriasis	9.97e-05	0.000332	CcSEcCtD
Imipramine—Anorexia—Methotrexate—psoriasis	9.96e-05	0.000332	CcSEcCtD
Imipramine—Urticaria—Prednisone—psoriasis	9.93e-05	0.000331	CcSEcCtD
Imipramine—Headache—Triamcinolone—psoriasis	9.91e-05	0.000331	CcSEcCtD
Imipramine—Abdominal pain—Prednisone—psoriasis	9.89e-05	0.00033	CcSEcCtD
Imipramine—Body temperature increased—Prednisone—psoriasis	9.89e-05	0.00033	CcSEcCtD
Imipramine—Diarrhoea—Betamethasone—psoriasis	9.82e-05	0.000328	CcSEcCtD
Imipramine—Diarrhoea—Dexamethasone—psoriasis	9.82e-05	0.000328	CcSEcCtD
Imipramine—Dizziness—Dexamethasone—psoriasis	9.5e-05	0.000317	CcSEcCtD
Imipramine—Dizziness—Betamethasone—psoriasis	9.5e-05	0.000317	CcSEcCtD
Imipramine—Insomnia—Methotrexate—psoriasis	9.45e-05	0.000315	CcSEcCtD
Imipramine—Nausea—Triamcinolone—psoriasis	9.4e-05	0.000313	CcSEcCtD
Imipramine—Paraesthesia—Methotrexate—psoriasis	9.38e-05	0.000313	CcSEcCtD
Imipramine—Somnolence—Methotrexate—psoriasis	9.29e-05	0.00031	CcSEcCtD
Imipramine—Dyspepsia—Methotrexate—psoriasis	9.2e-05	0.000307	CcSEcCtD
Imipramine—Vomiting—Betamethasone—psoriasis	9.13e-05	0.000304	CcSEcCtD
Imipramine—Vomiting—Dexamethasone—psoriasis	9.13e-05	0.000304	CcSEcCtD
Imipramine—Decreased appetite—Methotrexate—psoriasis	9.08e-05	0.000303	CcSEcCtD
Imipramine—Rash—Dexamethasone—psoriasis	9.05e-05	0.000302	CcSEcCtD
Imipramine—Rash—Betamethasone—psoriasis	9.05e-05	0.000302	CcSEcCtD
Imipramine—Dermatitis—Dexamethasone—psoriasis	9.05e-05	0.000302	CcSEcCtD
Imipramine—Dermatitis—Betamethasone—psoriasis	9.05e-05	0.000302	CcSEcCtD
Imipramine—Gastrointestinal disorder—Methotrexate—psoriasis	9.02e-05	0.000301	CcSEcCtD
Imipramine—Fatigue—Methotrexate—psoriasis	9.01e-05	0.0003	CcSEcCtD
Imipramine—Headache—Dexamethasone—psoriasis	9e-05	0.0003	CcSEcCtD
Imipramine—Headache—Betamethasone—psoriasis	9e-05	0.0003	CcSEcCtD
Imipramine—Asthenia—Prednisone—psoriasis	8.97e-05	0.000299	CcSEcCtD
Imipramine—Pruritus—Prednisone—psoriasis	8.85e-05	0.000295	CcSEcCtD
Imipramine—Feeling abnormal—Methotrexate—psoriasis	8.61e-05	0.000287	CcSEcCtD
Imipramine—Diarrhoea—Prednisone—psoriasis	8.56e-05	0.000285	CcSEcCtD
Imipramine—Gastrointestinal pain—Methotrexate—psoriasis	8.55e-05	0.000285	CcSEcCtD
Imipramine—Nausea—Dexamethasone—psoriasis	8.53e-05	0.000284	CcSEcCtD
Imipramine—Nausea—Betamethasone—psoriasis	8.53e-05	0.000284	CcSEcCtD
Imipramine—Urticaria—Methotrexate—psoriasis	8.3e-05	0.000277	CcSEcCtD
Imipramine—Dizziness—Prednisone—psoriasis	8.27e-05	0.000276	CcSEcCtD
Imipramine—Abdominal pain—Methotrexate—psoriasis	8.26e-05	0.000276	CcSEcCtD
Imipramine—Body temperature increased—Methotrexate—psoriasis	8.26e-05	0.000276	CcSEcCtD
Imipramine—Vomiting—Prednisone—psoriasis	7.95e-05	0.000265	CcSEcCtD
Imipramine—Rash—Prednisone—psoriasis	7.88e-05	0.000263	CcSEcCtD
Imipramine—Dermatitis—Prednisone—psoriasis	7.88e-05	0.000263	CcSEcCtD
Imipramine—Headache—Prednisone—psoriasis	7.83e-05	0.000261	CcSEcCtD
Imipramine—Asthenia—Methotrexate—psoriasis	7.5e-05	0.00025	CcSEcCtD
Imipramine—Nausea—Prednisone—psoriasis	7.43e-05	0.000248	CcSEcCtD
Imipramine—Pruritus—Methotrexate—psoriasis	7.39e-05	0.000247	CcSEcCtD
Imipramine—Diarrhoea—Methotrexate—psoriasis	7.15e-05	0.000238	CcSEcCtD
Imipramine—Dizziness—Methotrexate—psoriasis	6.91e-05	0.00023	CcSEcCtD
Imipramine—Vomiting—Methotrexate—psoriasis	6.64e-05	0.000222	CcSEcCtD
Imipramine—Rash—Methotrexate—psoriasis	6.59e-05	0.00022	CcSEcCtD
Imipramine—Dermatitis—Methotrexate—psoriasis	6.58e-05	0.00022	CcSEcCtD
Imipramine—Headache—Methotrexate—psoriasis	6.55e-05	0.000218	CcSEcCtD
Imipramine—Nausea—Methotrexate—psoriasis	6.21e-05	0.000207	CcSEcCtD
Imipramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.27e-05	0.00017	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—TYK2—psoriasis	1.26e-05	0.000169	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—CXCL8—psoriasis	1.26e-05	0.000169	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SOCS1—psoriasis	1.26e-05	0.000169	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—TYK2—psoriasis	1.25e-05	0.000168	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CARM1—psoriasis	1.25e-05	0.000168	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—LEP—psoriasis	1.24e-05	0.000167	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—APOE—psoriasis	1.24e-05	0.000167	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NFKBIA—psoriasis	1.23e-05	0.000165	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NFKBIA—psoriasis	1.23e-05	0.000165	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—CXCL8—psoriasis	1.21e-05	0.000162	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—CXCL8—psoriasis	1.2e-05	0.000161	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—TYK2—psoriasis	1.2e-05	0.000161	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—LEP—psoriasis	1.19e-05	0.00016	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—APOE—psoriasis	1.19e-05	0.00016	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—APOE—psoriasis	1.16e-05	0.000156	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—APOE—psoriasis	1.16e-05	0.000156	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SOCS1—psoriasis	1.16e-05	0.000156	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NFKBIA—psoriasis	1.16e-05	0.000155	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—CXCL8—psoriasis	1.15e-05	0.000154	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SOCS1—psoriasis	1.14e-05	0.000153	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SOCS1—psoriasis	1.14e-05	0.000153	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.14e-05	0.000152	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SOCS1—psoriasis	1.14e-05	0.000152	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SOCS1—psoriasis	1.13e-05	0.000152	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SOCS1—psoriasis	1.12e-05	0.00015	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—APOE—psoriasis	1.12e-05	0.00015	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—LEP—psoriasis	1.12e-05	0.00015	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SOCS1—psoriasis	1.12e-05	0.00015	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NFKBIA—psoriasis	1.11e-05	0.000149	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—TYK2—psoriasis	1.11e-05	0.000148	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CAT—psoriasis	1.11e-05	0.000148	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—CXCL8—psoriasis	1.1e-05	0.000147	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—CXCL8—psoriasis	1.09e-05	0.000146	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—TYK2—psoriasis	1.09e-05	0.000146	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—TYK2—psoriasis	1.09e-05	0.000146	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CAT—psoriasis	1.08e-05	0.000145	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—TYK2—psoriasis	1.08e-05	0.000145	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—APOE—psoriasis	1.08e-05	0.000145	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—TYK2—psoriasis	1.08e-05	0.000145	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—TYK2—psoriasis	1.07e-05	0.000143	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—TYK2—psoriasis	1.07e-05	0.000143	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—CXCL8—psoriasis	1.06e-05	0.000142	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CARM1—psoriasis	1.06e-05	0.000142	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—CXCL8—psoriasis	1.05e-05	0.00014	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—CXCL8—psoriasis	1.04e-05	0.00014	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NFKBIA—psoriasis	1.04e-05	0.00014	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—CXCL8—psoriasis	1.04e-05	0.00014	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—CXCL8—psoriasis	1.04e-05	0.000139	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—CXCL8—psoriasis	1.04e-05	0.000139	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—CXCL8—psoriasis	1.03e-05	0.000138	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—CXCL8—psoriasis	1.02e-05	0.000137	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—PPARG—psoriasis	1.01e-05	0.000136	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—PPARG—psoriasis	1.01e-05	0.000136	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TYK2—psoriasis	1.01e-05	0.000135	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TYK2—psoriasis	1.01e-05	0.000135	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—APOE—psoriasis	1e-05	0.000134	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.91e-06	0.000133	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—LEP—psoriasis	9.76e-06	0.000131	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—APOE—psoriasis	9.76e-06	0.000131	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—APOE—psoriasis	9.71e-06	0.00013	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—LEP—psoriasis	9.71e-06	0.00013	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—CXCL8—psoriasis	9.64e-06	0.000129	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TYK2—psoriasis	9.5e-06	0.000127	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—CXCL8—psoriasis	9.49e-06	0.000127	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—CXCL8—psoriasis	9.47e-06	0.000127	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—CXCL8—psoriasis	9.44e-06	0.000127	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—PPARG—psoriasis	9.43e-06	0.000126	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—CXCL8—psoriasis	9.41e-06	0.000126	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—CXCL8—psoriasis	9.32e-06	0.000125	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—LEP—psoriasis	9.3e-06	0.000125	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—APOE—psoriasis	9.3e-06	0.000125	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—CXCL8—psoriasis	9.29e-06	0.000125	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NFKBIA—psoriasis	9.1e-06	0.000122	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TYK2—psoriasis	9.09e-06	0.000122	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NFKBIA—psoriasis	9.05e-06	0.000121	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CXCL8—psoriasis	8.76e-06	0.000118	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CXCL8—psoriasis	8.76e-06	0.000117	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—PPARG—psoriasis	8.71e-06	0.000117	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NFKBIA—psoriasis	8.66e-06	0.000116	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—APOE—psoriasis	8.6e-06	0.000115	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—LEP—psoriasis	8.57e-06	0.000115	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—APOE—psoriasis	8.57e-06	0.000115	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TYK2—psoriasis	8.55e-06	0.000115	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—APOE—psoriasis	8.43e-06	0.000113	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—LEP—psoriasis	8.43e-06	0.000113	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—APOE—psoriasis	8.43e-06	0.000113	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—LEP—psoriasis	8.42e-06	0.000113	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—APOE—psoriasis	8.42e-06	0.000113	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—LEP—psoriasis	8.39e-06	0.000112	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—APOE—psoriasis	8.39e-06	0.000112	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CAT—psoriasis	8.37e-06	0.000112	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—APOE—psoriasis	8.36e-06	0.000112	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—LEP—psoriasis	8.36e-06	0.000112	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—IL6—psoriasis	8.33e-06	0.000112	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—IL6—psoriasis	8.33e-06	0.000112	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—LEP—psoriasis	8.28e-06	0.000111	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—APOE—psoriasis	8.28e-06	0.000111	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CXCL8—psoriasis	8.27e-06	0.000111	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—APOE—psoriasis	8.26e-06	0.000111	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—LEP—psoriasis	8.26e-06	0.000111	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CARM1—psoriasis	8.18e-06	0.00011	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CAT—psoriasis	8.17e-06	0.000109	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—JUN—psoriasis	8.15e-06	0.000109	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—JUN—psoriasis	8.14e-06	0.000109	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NFKBIA—psoriasis	7.99e-06	0.000107	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CXCL8—psoriasis	7.92e-06	0.000106	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—IL6—psoriasis	7.86e-06	0.000105	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NFKBIA—psoriasis	7.86e-06	0.000105	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—NFKB1—psoriasis	7.84e-06	0.000105	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NFKBIA—psoriasis	7.84e-06	0.000105	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—NFKB1—psoriasis	7.84e-06	0.000105	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NFKBIA—psoriasis	7.82e-06	0.000105	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NFKBIA—psoriasis	7.79e-06	0.000104	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NFKBIA—psoriasis	7.72e-06	0.000103	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CAT—psoriasis	7.7e-06	0.000103	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NFKBIA—psoriasis	7.7e-06	0.000103	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—JUN—psoriasis	7.69e-06	0.000103	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—IL6—psoriasis	7.53e-06	0.000101	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—PPARG—psoriasis	7.49e-06	0.0001	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TYK2—psoriasis	7.45e-06	9.99e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CXCL8—psoriasis	7.44e-06	9.98e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TYK2—psoriasis	7.41e-06	9.94e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—NFKB1—psoriasis	7.4e-06	9.92e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—JUN—psoriasis	7.36e-06	9.87e-05	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—PPARG—psoriasis	7.34e-06	9.84e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—VEGFA—psoriasis	7.12e-06	9.54e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—VEGFA—psoriasis	7.11e-06	9.53e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TYK2—psoriasis	7.1e-06	9.51e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—NFKB1—psoriasis	7.09e-06	9.5e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—IL6—psoriasis	7.08e-06	9.49e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—STAT3—psoriasis	7.05e-06	9.45e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—STAT3—psoriasis	7.04e-06	9.44e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—JUN—psoriasis	6.92e-06	9.28e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—VEGFA—psoriasis	6.72e-06	9e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—NFKB1—psoriasis	6.66e-06	8.93e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—STAT3—psoriasis	6.65e-06	8.91e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TYK2—psoriasis	6.54e-06	8.77e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CAT—psoriasis	6.52e-06	8.74e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—APOE—psoriasis	6.5e-06	8.72e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CXCL8—psoriasis	6.49e-06	8.7e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CXCL8—psoriasis	6.45e-06	8.65e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TYK2—psoriasis	6.44e-06	8.63e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—VEGFA—psoriasis	6.43e-06	8.62e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TYK2—psoriasis	6.42e-06	8.61e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TYK2—psoriasis	6.4e-06	8.58e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TYK2—psoriasis	6.38e-06	8.56e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—STAT3—psoriasis	6.37e-06	8.54e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APOE—psoriasis	6.35e-06	8.51e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TYK2—psoriasis	6.32e-06	8.47e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TYK2—psoriasis	6.3e-06	8.45e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CXCL8—psoriasis	6.18e-06	8.28e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—IL6—psoriasis	6.17e-06	8.27e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—IL6—psoriasis	6.14e-06	8.23e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—VEGFA—psoriasis	6.05e-06	8.11e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—JUN—psoriasis	6.03e-06	8.09e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—JUN—psoriasis	6e-06	8.04e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—STAT3—psoriasis	5.99e-06	8.03e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APOE—psoriasis	5.98e-06	8.02e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—IL6—psoriasis	5.88e-06	7.88e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—NFKB1—psoriasis	5.81e-06	7.78e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—NFKB1—psoriasis	5.78e-06	7.74e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—JUN—psoriasis	5.74e-06	7.7e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CXCL8—psoriasis	5.7e-06	7.64e-05	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—PPARG—psoriasis	5.66e-06	7.59e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CXCL8—psoriasis	5.61e-06	7.51e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CXCL8—psoriasis	5.59e-06	7.5e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CXCL8—psoriasis	5.58e-06	7.47e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—CXCL8—psoriasis	5.56e-06	7.45e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—NFKB1—psoriasis	5.53e-06	7.41e-05	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—PPARG—psoriasis	5.53e-06	7.41e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CXCL8—psoriasis	5.5e-06	7.38e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CXCL8—psoriasis	5.49e-06	7.36e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—IL6—psoriasis	5.42e-06	7.26e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—TP53—psoriasis	5.38e-06	7.21e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—TP53—psoriasis	5.37e-06	7.2e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—IL6—psoriasis	5.33e-06	7.15e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—IL6—psoriasis	5.32e-06	7.13e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—IL6—psoriasis	5.3e-06	7.11e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—JUN—psoriasis	5.3e-06	7.1e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—IL6—psoriasis	5.28e-06	7.08e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—VEGFA—psoriasis	5.27e-06	7.06e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—VEGFA—psoriasis	5.24e-06	7.03e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—IL6—psoriasis	5.23e-06	7.02e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—IL6—psoriasis	5.22e-06	7e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—STAT3—psoriasis	5.22e-06	7e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—JUN—psoriasis	5.21e-06	6.99e-05	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—PPARG—psoriasis	5.21e-06	6.98e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—JUN—psoriasis	5.2e-06	6.97e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—STAT3—psoriasis	5.19e-06	6.96e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—JUN—psoriasis	5.18e-06	6.95e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—JUN—psoriasis	5.17e-06	6.93e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—JUN—psoriasis	5.12e-06	6.86e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—JUN—psoriasis	5.1e-06	6.84e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—NFKB1—psoriasis	5.1e-06	6.83e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—TP53—psoriasis	5.07e-06	6.8e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APOE—psoriasis	5.07e-06	6.79e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CAT—psoriasis	5.03e-06	6.75e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—VEGFA—psoriasis	5.02e-06	6.73e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—NFKB1—psoriasis	5.02e-06	6.72e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—NFKB1—psoriasis	5.01e-06	6.71e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—NFKB1—psoriasis	4.99e-06	6.69e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—NFKB1—psoriasis	4.97e-06	6.67e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—STAT3—psoriasis	4.97e-06	6.66e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—NFKB1—psoriasis	4.92e-06	6.6e-05	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—IL6—psoriasis	4.92e-06	6.6e-05	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—IL6—psoriasis	4.92e-06	6.59e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—NFKB1—psoriasis	4.91e-06	6.58e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—TP53—psoriasis	4.86e-06	6.51e-05	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—IL6—psoriasis	4.64e-06	6.23e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—VEGFA—psoriasis	4.63e-06	6.2e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—STAT3—psoriasis	4.58e-06	6.14e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—TP53—psoriasis	4.57e-06	6.12e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—VEGFA—psoriasis	4.55e-06	6.1e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—VEGFA—psoriasis	4.54e-06	6.09e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—VEGFA—psoriasis	4.53e-06	6.07e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—VEGFA—psoriasis	4.51e-06	6.05e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—STAT3—psoriasis	4.51e-06	6.04e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—STAT3—psoriasis	4.5e-06	6.03e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—STAT3—psoriasis	4.48e-06	6.01e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—VEGFA—psoriasis	4.47e-06	5.99e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—STAT3—psoriasis	4.47e-06	5.99e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—VEGFA—psoriasis	4.46e-06	5.98e-05	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—IL6—psoriasis	4.45e-06	5.96e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—STAT3—psoriasis	4.43e-06	5.93e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—STAT3—psoriasis	4.41e-06	5.92e-05	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—PPARG—psoriasis	4.41e-06	5.92e-05	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—IL6—psoriasis	4.18e-06	5.61e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—TP53—psoriasis	3.98e-06	5.34e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—TP53—psoriasis	3.96e-06	5.31e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APOE—psoriasis	3.91e-06	5.24e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—TP53—psoriasis	3.79e-06	5.08e-05	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—IL6—psoriasis	3.64e-06	4.89e-05	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—IL6—psoriasis	3.63e-06	4.86e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—TP53—psoriasis	3.5e-06	4.69e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—IL6—psoriasis	3.47e-06	4.65e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—TP53—psoriasis	3.44e-06	4.61e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—TP53—psoriasis	3.43e-06	4.6e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—TP53—psoriasis	3.42e-06	4.59e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—TP53—psoriasis	3.41e-06	4.57e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—PPARG—psoriasis	3.41e-06	4.57e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—TP53—psoriasis	3.38e-06	4.53e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—TP53—psoriasis	3.37e-06	4.52e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—IL6—psoriasis	3.2e-06	4.29e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—IL6—psoriasis	3.15e-06	4.22e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—IL6—psoriasis	3.14e-06	4.21e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—IL6—psoriasis	3.13e-06	4.2e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—IL6—psoriasis	3.12e-06	4.19e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—IL6—psoriasis	3.09e-06	4.14e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—IL6—psoriasis	3.08e-06	4.13e-05	CbGpPWpGaD
